The Good News: The first clinical trial for healing an injured heart by using a subject’s own  stem cells is underway. Pfizer proactively and voluntarily halted a trial after results showed it was to likely to be successful.

The Bad News: The validity of clinical trials conducted China is under scrutiny because of too many positive results. A columnist says some trials may be rushed and done poorly to get drugs to market quickly.

All in all, another normal day of mixed news about whether trials are mostly helping or harming. Here’s to hoping that on this July 4 eve we start moving in a direction where there’s more good news than bad news for the American people and the global community.

Doubts Cast On Credibility Of Some Published Clinical Trials – Science Daily (press release) – USA- However, all RCTs of pre-market drug clinical trial were authentic, and RCTs conducted at hospitals affiliated with medical universities were more likely to … See all stories on this topic

Some clinical trials found to be biased – Examiner.com - USA – Recently there have been numerous reports suggesting that in the rush to get these drugs to the public, clinical trials may not only be poorly executed … See all stories on this topic

First Clinical Trials Completed of Adult Cardiac Stem Cell Repair – Lifesite – Pittsburgh, PA, USA – Milles is part of a 24-patient clinical trial that is the first test in using adult stem cells from a patient’s own heart to attempt to heal injured heart … See all stories on this topic

Clinical Trials Update – U.S. News & World Report – Washington, DC, USA – If your child (boys aged five to eight and girls aged five to seven) has had allergy symptoms for at least one year, he or she may qualify for this study … See all stories on this topic

Study of Sepracor’s Depression Drug Has Investors Gloomy – Inside Futures – Chicago, IL, USA – As if that disappointment was not bad enough, Sepracor received additional news about clinical trials of the pediatric Lunesta. Lunesta is the company’s … See all stories on this topic

FDA Approves Sanofi Heart Treatment – New York Times – United States – He called for more clinical trials. Stock analysts expect slow adoption of the drug, because of the cautions about its use, but ultimately consider it a … See all stories on this topic

Life Science Leader Magazine – Trials Or Tribulations: Does Patient Recruitment Offer Acceptable ROI? – Life Science Leader Magazine – Erie, PA, USA – Delays in meeting enrollment objectives for clinical trials are clearly a challenge that clinical teams will continue to face in the future … See all stories on this topic

Policy Shift On Stem Cell Research May Produce Effect Overseas – Life Science Leader Magazine – Erie, PA, USA – A total of 2147 clinical trials (Phase I-IV) for stem cell therapies overall were listed, as of June, on NIH’s website: www.ClinicalTrials.gov … See all stories on this topic

Life Science Leader Magazine – Bring Your Oncology Drug To Market Quicker: Think Patients First – Life Science Leader Magazine – Erie, PA, USA – Why is oncology clinical trial enrollment so difficult? The supply of adult cancer patients willing to participate in clinical trials remains stagnant at 3% … See all stories on this topic

Randomized trials published in some Chinese journals: how many are ... 7thSpace Interactive (press release) – New York, NY, USA – We investigated the adequacy of randomization of clinical trials published in recent years in China to determine how many of them met acceptable standards … See all stories on this topic

Pfizer’s Sutent fails in colon cancer, trial halted – Reuters – USA – Pfizer said it would continue to study Sutent in late-stage trials as a potential treatment for various other types of cancer and work to develop other … See all stories on this topic